ENvue Medical (FEED) Cash from Financing Activities (2014 - 2026)
ENvue Medical's (FEED) quarterly Cash from Financing Activities came in at $1.6 million in Q2 2026, down 76.73% year-over-year from $6.8 million in Q2 2025, and down 31.88% quarter-over-quarter from $2.3 million in Q1 2026.
Powered by 
Analysis
ENvue Medical (FEED) Cash from Financing Activities (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Cash from Financing Activities for 12 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 76.73% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $8.8 million, a 12.03% increase from a year earlier, with the FY2025 full-year figure at $12.8 million, up 1278500.0% from the prior year.
- Cash from Financing Activities was $1.6 million for Q2 2026 at ENvue Medical, down from $2.3 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $6.8 million in Q2 2025 and troughed at -$34000.0 in Q4 2025.
- A 4-year average of $2.3 million and a median of $1.6 million in 2026 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 100.64% in 2024 and jumped 18322.22% in 2025, its largest moves.
- Over 4 years, Cash from Financing Activities stood at $4.2 million in 2023, then plunged by 100.64% to -$27000.0 in 2024, then slipped by 25.93% to -$34000.0 in 2025, then jumped by 4788.24% to $1.6 million in 2026.
- The last three Cash from Financing Activities figures came in at $1.6 million (Q2 2026), $2.3 million (Q1 2026), and -$34000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -213.50 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | 1.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | -34,000.00 |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Sep 30, 2024 | -27,000.00 |
| Sep 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 7,000.00 |
| Sep 30, 2021 | 3.56 Mn |
| Jun 30, 2021 | -388,000.00 |
| Mar 31, 2021 | 1.41 Mn |
| Dec 31, 2020 | 5.26 Mn |
| Sep 30, 2020 | 4.02 Mn |
| Dec 31, 2019 | 112,000.00 |
| Sep 30, 2019 | 1.00 Mn |
| Jun 30, 2019 | 2.98 Mn |
| Mar 31, 2019 | 225,000.00 |
| Dec 31, 2018 | 50,000.00 |
| Sep 30, 2018 | 13,000.00 |